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ABSTRAK 
 
Perkaitan antara papilomavirus manusia (HPV) dengan papilomatosis larinks telah lama 
didokumentasi. Kami melaporkan dua kes papilomatosis larinks dan mengkorelasi kes-kes 
ini dengan kehadiran HPV, protein-protein p53 dan c-erbB-2. Kes yang pertama ialah 
seorang pesakit lelaki berumur satu tahun dan kes yang kedua, seorang pesakit 
perempuan berumur enam tahun. Spesimen biopsi yang berfiksasi formalin dan terbenam-
parafin telah diuji secara teknik in situ hibridisasi untuk kehadiran genom HPV. Teknik ini 
menggunakan prob-prob berbiotin yang spektrumnya luas dan jenis spesifik. Manakala 
ekspresi imunohistokimia pada protein-protein p53 (DO7, 1:50) dan c-erbB-2 (DAKO 
A0485, 1:300) dievaluasi dengan antibodi yang terdapat secara komersial. Secara 
histologi, tumor pada kedua-dua kes ini menunjukkan bentuk papilari pada papiloma 
skuamus. Kes pertama mengesan HPV jenis 6, HPV jenis 11 dan ekspresi protein p53 
manakala kes kedua hanya mempunyai HPV jenis 6. Kedua-dua kes HPV menunjukkan 
tanda positif terhad di nukleus pada epitelium skuamus superfisial. Kes yang pertama 
menunjukkan kepositifan p53 yang kelihatan di bahagian basal hingga satu per tiga 
epitelium papiloma larinks dan biopsi susulan yang  terkini menunjukkan kepositifan p53 
telah melanjut ke lapisan atasan epithelium. Ekspresi protein c-erbB-2 tidak dikesan pada 
kedua-dua kes ini. Penemuan ini adalah sama dengan kajian lain di mana pemantauan 
susulan klinikal pada kes-kes ini disyorkan kerana ia kecenderungan berulang. 
 
Kata kunci:  papilomatosis larinks juvenil, papilomavirus manusia, protein p53, protein c-
erbB-2 
 
 
ABSTRACT 
 
The association of human papillomavirus (HPV) with juvenile laryngeal papillomatosis has 
been well documented. We report two cases of juvenile laryngeal papillomatosis and 
correlated these cases with presence of HPV, p53 and c-erbB-2 proteins. The first case 
was a one-year-old male patient and the second a six-year-old female patient. Formalin-
fixed paraffin-embedded biopsy specimens were tested for the presence of HPV genome 
by the technique of in situ hybridisation using wide spectrum and type specific biotinylated 
probes while the immunohistochemical expression of p53 (D07, 1:50) and c-erbB-2 (DAKO 
A0485, 1:300) proteins were evaluated with commercially available antibodies. 
Histologically the tumours in both cases showed papillary configuration of squamous 
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papilloma. The first case detected HPV type 6, HPV type 11 and p53 protein expression 
while the second case showed only HPV type 6. Both cases of HPV showed positive 
signals confined to the nuclei in the superficial squamous epithelium. The first case 
showed p53 positivity seen from the basal region up to one third of the epithelium of 
laryngeal papillomas and the subsequent recent repeat biopsy showed the positivity of p53 
had extended throughout the upper layers of the epithelium.  Expression of c-erbB-2 
protein was not detected in both cases. These findings were similar as in other studies 
where follow-up of the cases was recommended since they tend to recur.  
 
Key words:  juvenile laryngeal papillomatosis, human papillomavirus, p53 protein, c-erbB-2 
protein 
 
 
 
INTRODUCTION 
 
Juvenile laryngeal papillomatosis are 
benign epithelial neoplasms of the 
laryngeal mucosa, often multiple and 
recurrent with a tendency to spread 
throughout the respiratory tract (Moore & 
Lattes, 1959).  The most common age of 
onset is during the first 5 years of life. The 
lesions may regress spontaneously at 
puberty but occasionally the patients will 
have recurrences throughout life. Juvenile 
multiple laryngeal papillomas are known to 
be caused by human papillomavirus (HPV) 
infection especially HPV-6 and HPV-11 
(Corbitt et al, 1988).  
P53 is the protein product of a tumour 
suppressor gene on the short arm of 
chromosome 17 (Isobe et al, 1986). It is 
involved in the regulation of the cell cycle 
and the triggering of apoptosis. Mutations 
of this tumour suppressor gene are 
amongst the commonest detected in 
human malignancies (Lane, 1994). While 
the wild-type (normal) p53 is not usually 
detected by immunohistochemistry as it 
has a short half-life (6-20 min), most 
genetic alterations result in the 
accumulation of a stabilised protein in the 
nucleus which is readily detectable by 
immunohistochemistry in paraffin-
embedded tissue (Levine, 1992; Wynford-
Thomas, 1992). Positivity indicates that the 
normal function of p53 in directing 
apoptosis of genetically abnormal cells is 
no longer operating in the cell. 
Oncoprotein c-erbB-2 (also known as 
neu/HER2) belongs to the family of the 
epidermal growth factor receptors, together 
with the Epidermal Growth Factor receptor 
(c-erb B1), Her3 (c-erb B3) and Her4 (c-erb 
B4), possesses tyrosine kinase activity, 
and is able to confer growth advantages to 
tumour cells overexpressing the protein 
and/or manifesting amplification of the 
cognate gene (Kurebayashi, 2001). c-erb 
B2 is a 185-kDa glycoprotein, which has 
been mapped to on chromosome 17q21 
(Akiyama et al, 1986). Amplification of the 
gene has been demonstrated in 
adenocarcinomas arising at a number of 
different sites as breast, ovary and 
gastrointestinal tract (Tal et al, 1988).   
Here we report two cases of laryngeal 
papillomas containing viral genomes of 
HPV by in situ hybridisation and p53 with  
c-erbB-2 protein expressions by immuno-
histochemical method.  
 
CASE REPORTS 
 
CASE 1 
 
In 1986, a one-year-old Chinese male baby 
lost his voice for three months duration, but 
he responded to call. There was no 
productive cough, fever or congenital 
abnormality. Before this episode he was 
crying and there was no significant illness 
of note. He was a full-term baby and he 
was delivered by spontaneous vaginal 
delivery. 
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Examination under general anaesthesia 
showed laryngeal papillomatosis. Since 
then he had more than 40 direct 
laryngoscopes and tracheoscopy in an 
attempt to eradicate the papillomas. In 
1987, a tracheostomy was performed.  
Interferon therapy for a duration of one 
month was started in 1988 but this failed to 
eradicate the disease. In 1991, the 
papilloma had spread to the stoma, 
subglottic area and the upper part of the 
trachea. 
Presently he is undergoing repeated 
direct laryngoscopy, tracheoscopy and 
plucking of the papillomas monthly. This is 
because the papillomas reappear after 
each surgical procedure. The latest biopsy 
was done in year 2001, and in 2002, he 
died of widespread involvement of the 
papillomas in the lungs. 
 
CASE 2 
 
A six years old Chinese girl from Johore 
presented to the Ear, Nose and Throat 
(ENT) clinic of Universiti Kebangsaan 
Malaysia (UKM) in 1993 complaining of 
hoarseness of the voice for the past one 
year. The hoarseness was gradual in onset 
but progressively increased in intensity. It 
was accompanied by productive cough 
with greenish sputum. There was no 
stridor, dyspnea or choking. 
Initially, she sought treatment at another 
hospital and a direct laryngoscopy was 
done. A diagnosis of left vocal cord 
papilloma was confirmed histologically. 
She was referred for further management 
in UKM. 
Examination under anesthesia, multiple 
laryngeal papillomatosis were detected 
arising from the left vocal cord, posterior 
half of left false cord and anterior 
commisure. 
Further biopsies and laser vaporization 
were done. Later, she was subjected to 
another laser vaporization. The papillo-
matosis had recurred in the same area and 
extended to one-third of the right vocal 
cord. There was no subglottic extension. 
Due to the persistent nature of this 
condition, she underwent further exami-
nation under anesthesia and repeated 
treatment. She was however lost to follow-
up. 
 
MATERIALS AND METHODS 
 
Both specimens consisted of multiple small 
fragmented laryngeal tissues, each 
measuring 4 x 3 cm and 1.5 x 1.5 x 1.5 cm 
in aggregate. 
The specimens were fixed in 10% 
buffered formalin and sampled in 
accordance with the departmental manual. 
Light microscopic slides were prepared 
from these tissues fixed in formalin, 
embedded in paraffin, cut at 4µm in 
thickness and stained with haematoxylin 
and eosin according to standard 
procedure.  
Laryngeal papillomatosis biopsy 
specimens at the time of diagnosis (the 
above specimens) and from the last 
subsequent procedure (done in 2001) were 
used for detection of both p53 and             
c-erbB-2 proteins.  
  
Detection of p53 and c-erbB-2 proteins by 
immunohistochemical staining 
 
Immunohistochemistry was performed on 
paraffin-embedded tissue using the 
labelled streptavidin biotin method 
(LSAB+kit, DAKO K 0690, Dako-
Cytomation, Glostrup, Denmark). The 
mouse monoclonal antibody against p53 
(DO-7, Dakopatts, at a dilution of 1:50) was 
used while polyclonal antibody against      
c-erbB-2 (DAKO A 0485, 1:300) was 
employed. 
Briefly, 3 µm sections were cut from the 
formalin-fixed, paraffin-embedded tissue 
blocks and mounted on silanized glass 
slides, deparaffinised, and placed in target 
retrieval solution (DAKO S1699, Dako-
Cytomation, Glostrup, Denmark) and in a 
microwave 600W for 10 minutes. The 
slides were left to cool in room temperature 
for 20 minutes and then washed again. 
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Subsequently, the slides were placed in 
3% hydrogen peroxide for 5 minutes at 
room temperature. The tissue sections 
were then incubated with anti-Human p53 
mouse monoclonal antibody (DO-7, 1:50) 
at room temperature for 30 minutes. 
After several washes with Tris buffered 
saline (TBS), sufficient amount of 
biotinylated linking antibody was applied 
and the sections were incubated at room 
temperature for 15 minutes followed by 
washing in three changes of TBS. Labelled 
Streptavidin Biotin (LSAB, Dako-
Cytomation, Glostrup, Denmark) was then 
applied and the slides were again 
incubated at room temperature for 15 
minutes and subsequently washed with 
three changes of TBS. 
Localisation of p53 was visualised by 
incubating the tissue sections for 10 
minutes in substrate-chromogen solution 
(Dako Corp, Carpenteria, California). The 
slides were finally washed under running 
tap water, counterstained with 
haematoxylin, dehydrated, cleared and 
mounted. The positive control was from a 
known p53 positive tissue section of an 
infiltrating ductal carcinoma, and the 
negative control was from the tissue 
section of the same case but without 
primary antibody. 
The reactivity for p53 protein was 
regarded as positive if distinct nuclear 
staining was present. Staining pattern was 
scored semi-quantitatively as follows: 0, no 
staining; 1, staining of the basal cells and 
suprabasal region up to one third of the 
epithelial thickness; 2, staining of two thirds 
of the epithelial thickness; and 3, staining 
throughout the epithelial thickness.  
Staining for c-erbB-2 was performed as 
described for p53 with minor modifications.  
Heating in the microwave (600W) for 20 
minutes was carried out followed by 
incubation with a 1:300 dilution of 
polyclonal rabbit anti-Human c-erbB-2 
(DAKO A 0485, DakoCytomation, Glostrup, 
Denmark) at room temperature for 30 
minutes. 
The positive control was taken from a 
known c-erbB-2 positive section of an 
infiltrating ductal carcinoma and the 
negative control was obtained from the 
tissue section of the same case as above 
but without primary antibody. 
c-erbB-2 positivity is scored according 
to: 0 = no membranous staining; 1+ = 
incomplete membranous staining; 2+ = 
membranous staining of moderate intensity 
in more than 10% neoplastic cells; 3+ = 
strong and complete membranous staining 
in more than 10% neoplastic cells.  
 
In situ hybridisation 
 
In situ hybridisation was performed using 
human papillomavirus DNA probes 
commercially obtained from Dako 
(Carpenteria, CA, USA) and In situ 
Hybridisation detection System (DAKO® in 
situ hybridisation detection system, Dako, 
Carpenteria, CA, USA), as described 
previously (12). The Wide Spectrum and 
the type specific HPV biotinylated DNA 
probes were prepared from HPV DNAs 
which were cloned into plasmid vectors. 
The targets for Wide Spectrum probe were 
the genomic DNAs of HPV types 6, 11, 16, 
18, 30, 31, 33, 35, 45, 51 and 52. The 
specific HPV probes used were types 6, 
11, 16, 18, 31 and 33. The positive control 
probe was prepared from total human 
DNA. The target was total genomic human 
DNA. The negative control was a plasmid 
DNA. 
Positive reactions for hybridisation were 
shown as blackish purple stain mainly in 
the nuclei of infected cells containing target 
DNA and negative reactions of the 
epithelial cells were stained as light pink. 
Typing with Type-Specific HPV probes was 
done on specimens showing positive 
signals with Wide Spectrum HPV probe. 
 
RESULTS 
 
Pathology findings 
 
The histological appearances of both 
tissues were typical of laryngeal 
papillomatosis. Microscopically, the papillo-
mata appeared as projections of kerati-
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nised stratified squamous epithelium 
overlying a fibrovascular core (Fig.1a). 
Parakeratosis and koilocytes were present 
and the latter appeared as vacuolated cells 
with clear cytoplasm. There was no atypia 
seen in these tissues.  
 
In situ hybridisation 
 
In situ hybridisation study detected specific 
signals of HPV-6 DNA in both cases and 
HPV-11 DNA in only the first case. The 
other viral types were not identified. The 
specific signal was observed as dense and 
homogenous, blackish purple nuclear stain, 
located in the superficial squamous 
epithelial cells (Fig. 1b&c).     
 
p53 and c-erbB-2 protein expressions 
 
For the first case, tissue blocks from biopsy 
taken at onset and the latest biopsy in 
2001 were selected after examination of 
the haematoxylin and eosin stained tissue 
sections. By immunohistochemistry, the 
first section showed positive staining for 
p53 protein, most pronounced in the lower 
third of the epithelium with focal inter-
mediate staining, while section from the 
latest biopsy showed the staining had 
extended to the intermediate layer in a 
diffuse pattern (Fig. 2 & 3).   
For the second case, tissue blocks 
available from the biopsy taken at 
presentation showed patchy staining of p53 
protein in the basal layer.  
For both cases, immunohistochemical 
staining for c-erbB-2 were negative. 
 
DISCUSSION 
 
Juvenile laryngeal papillomas (LP) present 
in children or adolescents with multiple 
papillary tumours on the true cords, from 
which they spread to the false cords, 
epiglottis and subglottic area, and in rare 
cases even to the trachea and bronchi 
(Moore, 1959). The long period of 
papilloma infection of the larynx is reflected 
by the fact that our first patient required a 
tracheostomy at some stage of the 
disease. The more aggressive behaviour of 
the papilloma has also resulted in this 
patient requiring laser treatment.  
Two types of HPV have been specifically 
associated with laryngeal papillomas. 
These are HPV-11, which was originally 
detected and cloned from a benign 
laryngeal papilloma and HPV-6 where it 
was isolated from a condyloma 
acuminatum (genital wart) and sub-
sequently shown to be associated with 
condyloma acuminata and laryngeal 
papillomas (LPs) in adults and children 
(Gissman  &   zur Hansen, 1980; Mounts et 
al, 1982). Both our cases were associated 
with HPV-6 and the first case had an 
additional HPV-11 which has been proved 
to be the most refractory to treatment 
(Hartley et al, 1994). 
A variety of human tumours exhibit 
mutations in the p53 gene that can lead to 
increased stability of its protein, resulting in 
increased immunostaining (Lane, 1994). 
Overexpression of p53 protein is commonly 
demonstrable in benign epithelial lesions of 
the upper respiratory tract. A study showed 
that in LPs, overexpression of p53 protein 
increased with the grade of epithelial 
abnormalities. The distribution of positive 
cells changed from scattered and focal, in 
simple and abnormal hyperplasia, to 
diffuse in atypical hyperplasia (Luzar et al, 
1997).  
The HPVs produce two separate viral 
proteins, one of them an E6 viral protein, is 
not interactive with HPV-6 and HPV-11, 
and both are most frequently found in LPs 
(Knudson, 1993). Thus, in the presence of 
HPV-6 and HPV-11, p53 protein can still 
preserve its tumor-suppressor activity in LP 
and this may account for the significant 
lower rate of malignant transformation of 
LP (Luzar et al, 1997). 
Another study identified 12 patients with 
recurrent laryngeal papillomatosis for a 
minimum of five years and each patient 
had at least three biopsies done; one 
biopsy was at the time of diagnosis, one at 
an intermediate time during treatment and 
the third from the last procedure (Rabah et 
al, 2000). They concluded that HPV typing, 
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FIGURE 1: Histological section of laryngeal papillommatosis (Case 1) (Haematoxylin & 
eosin, a, x20). Cells containing HPV 6 DNA by in situ hybridisation, indicated 
by the dark-stained nuclei of the superficial cells (b, x40 & c, x400) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Layngeal papillomatosis. Histological section from Case 1 showing nuclear 
staining for p53 protein in the cells within the basal layer, and a few positive 
cells in the upper epithelial cells. (Immunoperoxidase, a, x 40; b, x400) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3: Laryngeal papillomatosis. Histological section from Case 1 showing nearly 
diffuse nuclear staining of p53 protein throughout the epithelial thickness 
(Immunoperoxidase stain, x20) 
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especially HPV-11 may be helpful in 
identifying patients with aggressive 
recurrent laryngeal papillomatosis and the 
weak association between p53 indexes 
and procedures per year and virus type 
may have some predictive value in 
identifying the aggressive type. Our first 
patient had HPV-11 and was followed-up 
for nearly 15 years and histologically, so 
far, no atypical changes were seen in the 
epithelium.  
Luzar et al showed c-erbB-2 protein was 
observed in the hyperplastic epithelium 
covering LPs, and staining increased with 
increasing grades of epithelial thickness 
(Luzar et al, 1997). Membranous staining is 
considered to indicate c-erbB-2 over-
expression, which is characteristically 
associated with c-erbB-2 amplification in 
breast carcinomas. With the increasing 
grade of epithelial abnormalities, cyto-
plasmic staining became predominant 
compared to membranous staining, and c-
erbB-2 positivity sometimes occupied the 
whole thickness. Both our cases showed 
no membranous staining. 
 
CONCLUSION 
 
One of the above cases followed-up had 
frequent recurrences and was shown to 
have HPV type 11 and p53 positive cells. 
These p53 positive cells were shown in the 
earlier specimen to be scattered and 
focally distributed, and follow-up biopsy 
after many years showed nearly diffuse 
distribution. These findings were similar as 
in other studies, where follow-up of the 
cases was recommended since they tend 
to recur (Luzar et al, 1997; Rabah et al, 
2000).  
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